Synchronyx Selected to Present at the 2026 Florida Venture Capital Conference
MIAMI, FLA. – January 27, 2026
Synchronyx, a digital health company focused on medication adherence and patient engagement, today announced it has been selected to present at the 2026 Florida Venture Capital Conference (FVCC), hosted by the Florida Venture Forum and held February 23–25, 2026 in Miami.
Synchronyx was chosen by a selection committee of active venture capital investors from a record-breaking number of applications. The 2026 conference features 63 companies—the largest cohort in the Florida Venture Forum’s 40-year history—representing the highest tier of innovation and growth potential in the region.
Synchronyx’s flagship platform, Tappt®, combines battery-free smart labels with a patient-facing experience to capture real-time, dose-level adherence signals and patient-reported context that explains missed doses, barriers, and care needs. The company’s approach is designed to move beyond refill proxies and enable more actionable intervention pathways across clinical, pharmacy, and commercial settings.
"Our selection for the Florida Venture Capital Conference comes at a period of significant commercial momentum for Synchronyx," said Tamar Sapir, PhD, CEO & Founder of Synchronyx. "We have successfully moved beyond proof-of-concept into a scaling commercial phase. By providing a validated, data-driven bridge between patients and the healthcare ecosystem, we are delivering measurable value to our partners in pharma, pharmacies, and health systems."
Synchronyx supports stakeholders across the medication ecosystem, including:
Pharma and life sciences teams seeking higher-quality real-world evidence and persistence insights in clinical and commercial programs
Pharmacies aiming to strengthen patient engagement and adherence performance with scalable workflows
Health systems and payer-facing initiatives that need more timely medication intelligence to reduce downstream complications
To connect during FVCC 2026: Investors and partners can request a meeting with the Synchronyx team during the conference dates.
The Florida Venture Capital Conference is the state’s premier event for connecting high-growth companies with institutional investors. For more information about Synchronyx and its award-winning Tappt® platform, visit www.synchronyx.com.
About Synchronyx
Synchronyx is an award-winning digital health company based in Boca Raton, Florida. Its Tappt® platform transforms medication packaging into a source of real-world intelligence, helping healthcare stakeholders improve patient adherence and outcomes through actionable, validated data.
About the Florida Venture Forum
The Florida Venture Forum is Florida’s largest statewide support organization for investors and entrepreneurs. Since 1984, the Forum has helped companies raise more than $11 billion in equity capital through its annual conferences and statewide programming.
Media Contact: info@synchronyx.com
